Achilles drops cell therapy program, braces for layoffs after …
2 days ago · Achilles Therapeutics has torn up its strategy. The British biotech is stopping work on its clinical-phase cell therapy, looking into deals with groups working on other modalities and preparing to lay off staff. London-based Achilles sounded committed to its tumor-infiltrating lymphocyte (TIL)-based therapy when it published updated …
Achilles Therapeutics Announces $12M AstraZeneca Deal, Plans …
4 days ago · Zinger Key Points. Achilles Therapeutics signs $12M deal with AstraZeneca for TRACERx data and tumor samples from lung cancer study. The company plans job cuts and Board reductions after ...
Syncona: Achilles Announces Sale Of Technology Assets To …
2 days ago · AstraZeneca has agreed to pay Achilles $12 million for the assets in total. Achilles plans to undertake additional measures, including a reduction in employee headcount and a decrease in the size ...
Achilles Therapeutics sells technology assets to AstraZeneca for …
3 days ago · Achilles Therapeutics (ACHL) announced that it has transferred the commercial license of data and samples from the TRACERx Non-Small Cell Lung Cancer study to AstraZeneca (AZN). TRACERx, led by ...
Achilles Therapeutics Transfers TRACERx Data and MAP Assets to ...
4 days ago · Potential Positives. Achilles Therapeutics has successfully secured $12 million through the licensing of its TRACERx and MAP assets to AstraZeneca, indicating a strong financial move for the company.
Job losses loom at Achilles as TIL therapy platform is cut
Sep 20, 2024 · Employees at Achilles Therapeutics are bracing themselves for job losses after the UK biotech announced that it is dropping its R&D in tumour-infiltrating lymphocyte (TIL) therapies for cancer...
Achilles drops cell therapy program, braces for layoffs
Sep 19, 2024 · Achilles Therapeutics has torn up its strategy. The British biotech is stopping work on its clinical-phase cell therapy, looking into deals with groups working on other modalities and preparing...
Achilles Therapeutics Sells Technology Assets to AstraZeneca for …
4 days ago · Achilles Therapeutics has sold certain technology assets to drug giant AstraZeneca for $12 million following a review of strategic alternatives by the clinical-stage biopharmaceutical company ...
News Releases | Achilles
Nov 19, 2024 · Explore the latest innovations, and milestones at Achilles right here. Stay informed about our cutting-edge technologies, strategic collaborations, and success stories that define our commitment to excellence.
Achilles Therapeutics Announces Sale of Technology Assets
4 days ago · Achilles is a clinical-stage biopharmaceutical company that has been developing AI-powered precision T cell therapies targeting clonal neoantigens: protein markers unique to the individual that ...
- Some results have been removed